» Articles » PMID: 33313143

A New Sarcopenia Score Prognostic for Postoperative Complications in Hepatic Alveolar Echinococcosis: a Multicenter Retrospective Study

Overview
Journal Ann Transl Med
Date 2020 Dec 14
PMID 33313143
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Skeletal muscle depletion and excessive visceral adipose tissue have been shown to be independent risk factors for postoperative complications (PCs) in various diseases. However, their impact on surgical PCs in hepatic alveolar echinococcosis (HAE) is still unknown.

Methods: We retrospectively reviewed the clinical data of HAE patients who underwent liver resection at our hospital between January 2008 and December 2018. We segmented skeletal muscle and adipose tissue and measured the area of skeletal muscle tissue and adipose tissue at the level of the third lumbar vertebra by manual tracing from preoperative plain computed tomography (CT) images. Sarcopenia features were selected to construct a formula based on the least absolute shrinkage and selection operator (LASSO) logistic regression model in the primary set. Then, integrating the results of multiple clinicopathologic characteristics, we built a nomogram for predicting major PCs in HAE. The results were validated using bootstrap resampling and clinical data from other HAE centers in western China.

Results: The sarcopenia score is based on the personalized levels of the five features from the primary set (n=233). In the multivariate logistic analysis of the primary set, the independent factors for PCs were γ-glutamyl transferase (GGT), and surface area of hepatectomy, which were integrated into the nomogram combined with sarcopenia score. The model had a good prediction capability with a C-index of 0.84 (95% CI, 0.72-0.96). The calibration plot for the probability of PCs showed an optimal agreement between the nomogram predictions and actual observations in the primary and validation sets.

Conclusion: Our study showed that sarcopenia score was significantly correlated with PCs in patients with HAE. In addition, we constructed a prognostic nomogram for predicting complications in HAE patients after liver surgery. The nomogram displayed excellent discrimination and calibration. Improving the nutritional status and physical health of patients before surgery might reduce the incidence of postoperative complications for the high-risk patients.

Citing Articles

[Relationship Between the Level of Anatomical Risk of Hepatic Alveolar Echinococcosis and Complications after Radical Resection].

Zhi M, Pang H, Wang W Sichuan Da Xue Xue Bao Yi Xue Ban. 2022; 53(5):770-776.

PMID: 36224677 PMC: 10408804. DOI: 10.12182/20220960108.


A Sarcopenia-Based Prediction Model for Postoperative Complications of ex vivo Liver Resection and Autotransplantation to Treat End-Stage Hepatic Alveolar Echinococcosis.

Sun T, Wang T, Qiu Y, Shen S, Yang X, Yang Y Infect Drug Resist. 2021; 14:4887-4901.

PMID: 34848980 PMC: 8627200. DOI: 10.2147/IDR.S340478.

References
1.
Labgaa I, Joliat G, Demartines N, Hubner M . Serum albumin is an early predictor of complications after liver surgery. Dig Liver Dis. 2016; 48(5):559-561. DOI: 10.1016/j.dld.2016.01.004. View

2.
Qiu Y, Yang X, Shen S, Huang B, Wang W . Vascular infiltration-based surgical planning in treating end-stage hepatic alveolar echinococcosis with ex vivo liver resection and autotransplantation. Surgery. 2018; 165(5):889-896. DOI: 10.1016/j.surg.2018.11.007. View

3.
Suh B, Park S, Shin D, Yun J, Keam B, Yang H . Low albumin-to-globulin ratio associated with cancer incidence and mortality in generally healthy adults. Ann Oncol. 2014; 25(11):2260-2266. DOI: 10.1093/annonc/mdu274. View

4.
Joglekar S, Asghar A, Mott S, Johnson B, Button A, Clark E . Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma. J Surg Oncol. 2015; 111(6):771-5. PMC: 4406850. DOI: 10.1002/jso.23862. View

5.
Johnson P, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves H . Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2014; 33(6):550-8. PMC: 4322258. DOI: 10.1200/JCO.2014.57.9151. View